IFNA1 and depressive disorder: Despite reduced levels of peripheral TRP, the central levels of TRP do not appear to be affected by IFN-a treatment (Raison et al., 2010), raising the possibility that neurotoxic end-products rather than serotonin play a role in the pathology of depression.